This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post‐transplant Recurrence: Final Results of the ALLY‐1 Study: 2016 ACG Presidential Poster Award: 774. (October 2016)
Record Type:
Journal Article
Title:
Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post‐transplant Recurrence: Final Results of the ALLY‐1 Study: 2016 ACG Presidential Poster Award: 774. (October 2016)
Main Title:
Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post‐transplant Recurrence: Final Results of the ALLY‐1 Study: 2016 ACG Presidential Poster Award